Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Free Full Text Free
Right arrow Free Full Text (Free PDF) Free
Right arrow All Versions of this Article:
0192623308322307v1
36/6/858    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hayashi, S.
Right arrow Articles by Wanibuchi, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayashi, S.
Right arrow Articles by Wanibuchi, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ERYTHROMYCIN
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Articles

Characterization of Multinuclear Hepatocytes Induced in Rats by Mitemcinal (GM-611), an Erythromycin Derivative

Shuji Hayashi1, Etsuko Fujii1, Atsuhiko Kato1, Kazuya Kimura1, Keiji Mizoguchi1, Masami Suzuki1, Tetsuro Sugimoto1, Hisanori Takanashi1, Zen Itoh2, Satoshi Omura3 and Hideki Wanibuchi4

1 Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan
2 Gunma University, Maebashi, Gunma, Japan
3 The Kitasato Institute, Minato-ku, Tokyo, Japan
4 Osaka City University Medical School, Abeno-ku, Osaka, Japan

Correspondence: Shuji Hayashi, Safety Assessment Department, Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., LTD. 1–135 Komakado, Gotemba, Shizuoka 412–8513, Japan; E-mail:hayashisuj{at}chugai-pharm.co.jp

Mitemcinal is an erythromycin derivative with motilin agonistic action, developed as a gastrointestinal motor-activating agent. The characteristics of mitemcinal-induced multinuclear hepatocytes (MNHs, hepatocytes with three or more nuclei per cell) from detailed morphological observations together with the results of a study on the mechanisms of MNH formation by combining cytocentrifuge preparations with 5-bromo-2’-deoxyuridine cumulative labeling are reported. MNHs were observed only in rats in the high-dose groups of the subchronic study, with a higher incidence in females and reversibility after twenty-eight days of drug withdrawal, but not observed in dogs. In the chronic study, the incidence increased relative to the dose. Histopathologically, MNHs were preferentially observed in the centrilobular zone, without nuclear atypia or mitotic figures. In the cell kinetic study, the labeling pattern of MNHs included all-positive, all-negative, and mixed labeling patterns of nuclei. The all-negative pattern indicated that the cells were formed by fusion of nondividing cells. The current results indicate that the cell kinetic approach effectively demonstrated the mechanism of mitemcinal-induced MNHs as fusion of hepatocytes and that drug-induced disturbance of mitosis is not involved in the multinucleation of MNHs by mitemcinal.

Key Words: bromodeoxyuridine • cell kinetics • cytocentrifuge preparations • mitemcinal • multinuclear hepatocyte • nuclearity • rats

Abbreviations: BrdU, 5-bromo-2’-deoxyuridine • MNH, multinuclear hepatocyte

This version was published on October 1, 2008

Toxicologic Pathology, Vol. 36, No. 6, 858-865 (2008)
DOI: 10.1177/0192623308322307


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?